| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PEREGRINE PHARMACEUTICALS IN | 350,000 | 357,000 | 0.14% | ||
| 2 | CYMABAY THERAPEUTICS INC | 250,000 | 485,000 | 0.19% | ||
| 3 | MEI PHARMA INC | 325,000 | 510,000 | 0.20% | ||
| 4 | Marinus Pharmaceuticals Inc | 75,000 | 626,000 | 0.25% | ||
| 5 | NEVRO CORP | 15,000 | 696,000 | 0.27% | Call | |
| 6 | Arrowhead Pharma Inc | 125,000 | 720,000 | 0.28% | ||
| 7 | DICERNA PHARMACEUTICALS INC | 100,000 | 821,000 | 0.32% | ||
| 8 | ADAPTIMMUNE THERAPEUTICS PLC | 75,000 | 898,000 | 0.35% | ||
| 9 | SCYNEXIS INC | 125,000 | 910,000 | 0.36% | ||
| 10 | SUPERNUS PHARMACEUTICALS INC | 65,000 | 912,000 | 0.36% | Call | |
| 11 | IMMUNE DESIGN CORP | 75,000 | 915,000 | 0.36% | ||
| 12 | REVANCE THERAPEUTICS INC COM | 35,000 | 1,042,000 | 0.41% | ||
| 13 | OCULAR THERAPEUTIX INC | 75,000 | 1,055,000 | 0.41% | ||
| 14 | ARIAD PHARMACEUTICALS ORD (NMS) | 125,000 | 1,058,000 | 0.42% | ||
| 15 | AERIE PHARMACEUTICALS INC COM | 60,015 | 1,065,000 | 0.42% | ||
| 16 | IGNYTA INC COM | 125,000 | 1,098,000 | 0.43% | ||
| 17 | GENESIS HEALTHCARE INC | 180,000 | 1,103,000 | 0.43% | ||
| 18 | ESPERION THERAPEUTICS INC | 50,000 | 1,180,000 | 0.46% | Call | |
| 19 | Esperion Therapeutics Inc | 50,000 | 1,180,000 | 0.46% | ||
| 20 | ALNYLAM PHARMACEUTICALS INC | 15,000 | 1,205,000 | 0.47% | ||
| 21 | ZAFGEN INC COM | 40,000 | 1,278,000 | 0.50% | ||
| 22 | CONATUS PHARMACEUTICALS INC | 300,000 | 1,335,000 | 0.53% | ||
| 23 | BROOKDALE SR LIVING INC | 60,000 | 1,378,000 | 0.54% | ||
| 24 | EPIZYME INC COM | 110,000 | 1,415,000 | 0.56% | ||
| 25 | ASSEMBLY BIOSCIENCES INC | 150,000 | 1,434,000 | 0.56% | ||
| 26 | ARIAD PHARMACEUTICALS INC | 250,000 | 1,460,000 | 0.57% | Call | |
| 27 | PTC THERAPEUTICS INC | 60,000 | 1,602,000 | 0.63% | Call | |
| 28 | APPLIED GENETIC TECHNOL CORP | 125,000 | 1,643,000 | 0.65% | ||
| 29 | VANDA PHARMACEUTICALS INC COM | 150,000 | 1,692,000 | 0.67% | ||
| 30 | SAGE THERAPEUTICS INC | 40,000 | 1,693,000 | 0.67% | ||
| 31 | DERMIRA INC COM | 75,000 | 1,751,000 | 0.69% | ||
| 32 | Hercules Offshore Inc | 160,000 | 1,779,000 | 0.70% | ||
| 33 | ENDOLOGIX INC | 150,000 | 1,839,000 | 0.72% | ||
| 34 | SUPERNUS PHARMACEUTICALS INC | 135,000 | 1,894,000 | 0.74% | ||
| 35 | ONCOMED PHARMACEUTICALS INC COM | 125,000 | 2,074,000 | 0.82% | ||
| 36 | SPARK THERAPEUTICS INC | 50,000 | 2,087,000 | 0.82% | Put | |
| 37 | WRIGHT MEDICAL GROUP NV | 100,000 | 2,102,000 | 0.83% | ||
| 38 | NUVASIVE INC | 50,000 | 2,411,000 | 0.95% | ||
| 39 | ACCELERATE DIAGNOSTICS INC | 150,000 | 2,427,000 | 0.95% | ||
| 40 | IMPAX LABORATORIES INC | 75,000 | 2,641,000 | 1.04% | ||
| 41 | ACCELERON PHARMA INC | 110,000 | 2,739,000 | 1.08% | ||
| 42 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 65,000 | 2,740,000 | 1.08% | ||
| 43 | MEDIVATION INC | 70,000 | 2,975,000 | 1.17% | ||
| 44 | WRIGHT MEDICAL GROUP N.V. | 150,000 | 3,059,000 | 1.20% | ||
| 45 | VCA INCORPORATED | 60,000 | 3,159,000 | 1.24% | ||
| 46 | ALLSCRIPTS HEALTHCARE SOLUTN | 260,000 | 3,224,000 | 1.27% | ||
| 47 | ABBVIE INC | 60,000 | 3,264,000 | 1.28% | Call | |
| 48 | LA JOLLA PHARMACEUTICAL CO | 125,000 | 3,474,000 | 1.37% | ||
| 49 | GW PHARMACEUTICALS PLC | 40,000 | 3,655,000 | 1.44% | ||
| 50 | Merck & Co Inc Call Opt 01/18 67.5 | 75,000 | 3,704,000 | 1.46% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-15-000013, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
